Yuki Sato

Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study

Shunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto et al. · Journal of Thoracic Oncology · 2017 · 377 citations · Full text

Medicine, Immunology, Oncology +14

A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis

Satoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu et al. · Journal of Thoracic Oncology · 2020 · 103 citations · Full text

Medicine, Oncology, Pharmacology +5

Success Rate of Gingivoperiosteoplasty with and without Secondary Bone Grafts Compared with Secondary Alveolar Bone Grafts Alone

Yuki Sato, Barry H. Grayson, Judah S. Garfinkle et al. · Plastic & Reconstructive Surgery · 2008 · 92 citations

Dentistry, Maxillofacial Surgery, Oral Surgery +15

Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT)

Yoshihiko Sakata, Shinya Sakata, Yuko Oya et al. · European Journal of Cancer · 2021 · 89 citations

Medicine, Oncology, Pharmacology +12

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients

Daichi Fujimoto, Keiichiro Uehara, Yuki Sato et al. · Scientific Reports · 2017 · 87 citations · Full text

Medicine, Oncology, Radiation Oncology +17